Flyer

Health Science Journal

  • ISSN: 1108-7366
  • Journal h-index: 61
  • Journal CiteScore: 17.30
  • Journal Impact Factor: 18.23
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
Share This Page

Hypercalcemia and Chronic Renal Failure: a Case of Tertiary Hyperparathyroidism

XX Congresso Regionale FADOI CAMPANIA: Non ci siamo mai fermati
Italy 2021

Tibullo L*, Nunziata M, Varella P, Atteno M, Mastroianni M, Antignani G and Amitrano M

Internal Medicine Ward, San Giuseppe Moscati Hospital, Avellino, Italy
Nuclear Medicine Ward, San Giuseppe Moscati Hospital, Avellino, Italy

Posters & Accepted Abstracts: Health Sci J

Abstract:

Background: Hyperparathyroidism is a clinical condition related to the excessive synthesis and secretion of the parathyroid hormone secreted by the parathyroid glands. It exerts a hypercalcemic effect. We distinguish three forms of hyperparathyroidism: primary, secondary and tertiary [1]. Case history: We report the case of a 79-year-old woman who came to our observation for asthenia, osteoarticular pain, and anaemia, suffering from chronic renal failure (IV stage). Blood chemistry tests show macrocytic anaemia with normal reticulocytes and haptoglobin, and vitamin B12 deficiency, increased creatinine, azotemia, and hypercalcemia. An ultrasound scan of the thyroid and parathyroid glands is then performed, showing a hypoechoic nodule of possible parathyroid relevance in the right lobe in the basal area. A high parathyroid hormone dosage is performed; therefore, parathyroid scintigraphy is performed with Sestamibi, confirming the suspicion of parathyroid adenoma. We then performed the cytological examination of the nodule at the base of the right thyroid lobe and intranodular dosage of the parathyroid hormone. Both samples were consistent with the diagnosis of adenomatous/hyperplastic parathyroid nodule. Discussion: The authors investigated the finding of hypercalcemia and chronic renal failure to identify parathyroid hyperplasia, a condition that identifies tertiary hyperparathyroidism. References 1 Palumbo VD, Palumbo VD, Damiano G, Messina M, Fazzotta S, et al. (2021) Tertiary hyperparathyroidism: a review. AI.Clin Ter 172: 241- 246.